blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2019837

EP2019837 - COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.01.2012
Database last updated on 13.11.2024
Most recent event   Tooltip18.10.2013Lapse of the patent in a contracting state
New state(s): TR		published on 20.11.2013  [2013/47]
Applicant(s)For all designated states
IRM LLC
131 Front Street P.O. Box HM 2899
Hamilton HM LX / BM
[2011/01]
Former [2009/06]For all designated states
IRM LLC
Hurst Holme 12 Trott Road
Hamilton HM 11 / BM
Inventor(s)01 / TULLY, David, C.
4278 Calle Isabelino
San Diego, California 92130 / US
02 / CHATTERJEE, Arnab, K.
439 3rd Street
Encinitas, California 92024 / US
03 / PETRASSI, Hank, Michael, James
1329 Caminito Septimo
Cardiff, California 92007 / US
04 / BURSULAYA, Badry
8278 Avenida Navidad, Suite 2
San Diego, California 92122 / US
05 / SPRAGGON, Glen
3311 Geddes Drive
San Diego, California 92117 / US
 [2009/06]
Representative(s)Kiddle, Simon John, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2009/06]Kiddle, Simon John, et al
Mewburn Ellis LLP 33 Gutter Lane London
EC2V 8AS / GB
Application number, filing date07762204.115.05.2007
[2009/06]
WO2007US68987
Priority number, dateUS20060808014P23.05.2006         Original published format: US 808014 P
US20060860622P22.11.2006         Original published format: US 860622 P
[2009/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007140117
Date:06.12.2007
Language:EN
[2007/49]
Type: A1 Application with search report 
No.:EP2019837
Date:04.02.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 06.12.2007 takes the place of the publication of the European patent application.
[2009/06]
Type: B1 Patent specification 
No.:EP2019837
Date:23.03.2011
Language:EN
[2011/12]
Search report(s)International search report - published on:EP06.12.2007
ClassificationIPC:C07K5/06, C07K5/08, A61K38/05, A61K38/06, A61K38/55, A61P11/00, A61P11/06, A61P11/10
[2010/42]
CPC:
C07K5/0806 (EP,US); C07D207/16 (KR); A61K38/55 (KR);
A61P11/00 (EP); A61P11/06 (EP); A61P11/08 (EP);
A61P11/10 (EP); A61P29/00 (EP); A61P31/00 (EP);
A61P35/00 (EP); A61P43/00 (EP); C07K5/06 (KR);
C07K5/06165 (EP,US); A61K38/00 (EP,US) (-)
Former IPC [2009/06]C07K5/06, C07K5/08, A61K38/55, A61P11/00, A61P11/06, A61P11/10
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/06]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:VERBINDUNGEN UND ZUSAMMENSETZUNGEN ALS KANALAKTIVIERENDE PROTEASE-HEMMER[2009/06]
English:COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS[2009/06]
French:COMPOSÉS ET COMPOSITIONS INHIBANT LES PROTÉASES ACTIVATRICES DE CANAUX[2009/06]
Entry into regional phase27.03.2008National basic fee paid 
27.03.2008Designation fee(s) paid 
27.03.2008Examination fee paid 
Examination procedure27.03.2008Examination requested  [2009/06]
20.08.2009Despatch of a communication from the examining division (Time limit: M04)
17.12.2009Reply to a communication from the examining division
07.10.2010Communication of intention to grant the patent
09.02.2011Fee for grant paid
09.02.2011Fee for publishing/printing paid
Opposition(s)27.12.2011No opposition filed within time limit [2012/09]
Fees paidRenewal fee
20.05.2009Renewal fee patent year 03
31.03.2010Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY23.03.2011
CZ23.03.2011
DK23.03.2011
EE23.03.2011
FI23.03.2011
HU23.03.2011
LT23.03.2011
LV23.03.2011
MT23.03.2011
RO23.03.2011
SE23.03.2011
SI23.03.2011
SK23.03.2011
TR23.03.2011
IE15.05.2011
LU15.05.2011
MC31.05.2011
BG23.06.2011
IS23.07.2011
[2013/47]
Former [2013/45]CY23.03.2011
CZ23.03.2011
DK23.03.2011
EE23.03.2011
FI23.03.2011
HU23.03.2011
LT23.03.2011
LV23.03.2011
MT23.03.2011
RO23.03.2011
SE23.03.2011
SI23.03.2011
SK23.03.2011
IE15.05.2011
LU15.05.2011
MC31.05.2011
BG23.06.2011
IS23.07.2011
Former [2013/25]CY23.03.2011
CZ23.03.2011
DK23.03.2011
EE23.03.2011
FI23.03.2011
LT23.03.2011
LV23.03.2011
MT23.03.2011
RO23.03.2011
SE23.03.2011
SI23.03.2011
SK23.03.2011
IE15.05.2011
LU15.05.2011
MC31.05.2011
BG23.06.2011
IS23.07.2011
Former [2012/20]CY23.03.2011
CZ23.03.2011
DK23.03.2011
EE23.03.2011
FI23.03.2011
LT23.03.2011
LV23.03.2011
MT23.03.2011
RO23.03.2011
SE23.03.2011
SI23.03.2011
SK23.03.2011
IE15.05.2011
MC31.05.2011
BG23.06.2011
IS23.07.2011
Former [2012/12]CY23.03.2011
CZ23.03.2011
DK23.03.2011
EE23.03.2011
FI23.03.2011
LT23.03.2011
LV23.03.2011
MT23.03.2011
RO23.03.2011
SE23.03.2011
SI23.03.2011
SK23.03.2011
MC31.05.2011
BG23.06.2011
IS23.07.2011
Former [2012/05]CY23.03.2011
CZ23.03.2011
EE23.03.2011
FI23.03.2011
LT23.03.2011
LV23.03.2011
MT23.03.2011
RO23.03.2011
SE23.03.2011
SI23.03.2011
SK23.03.2011
MC31.05.2011
BG23.06.2011
IS23.07.2011
Former [2011/50]CY23.03.2011
CZ23.03.2011
EE23.03.2011
FI23.03.2011
LT23.03.2011
LV23.03.2011
RO23.03.2011
SE23.03.2011
SI23.03.2011
SK23.03.2011
BG23.06.2011
IS23.07.2011
Former [2011/49]CY23.03.2011
CZ23.03.2011
EE23.03.2011
FI23.03.2011
LT23.03.2011
LV23.03.2011
RO23.03.2011
SE23.03.2011
SI23.03.2011
SK23.03.2011
BG23.06.2011
Former [2011/37]CY23.03.2011
FI23.03.2011
LT23.03.2011
LV23.03.2011
SE23.03.2011
SI23.03.2011
BG23.06.2011
Former [2011/36]LT23.03.2011
LV23.03.2011
SE23.03.2011
Cited inInternational search[X]WO9640748  (ORTHO PHARMA CORP [US]) [X] 1-16,18,20,21,25-27 * page 26 - page 27; example Ik *;
 [A]WO9731939  (AKZO NOBEL NV [NL], et al) [A] 1-27 * example 52 *;
 [A]WO9807308  (AKZO NOBEL NV [NL], et al) [A] 1-27 * example 6 *;
 [A]  - DONNELLY L E ET AL, "THERAPY FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE 21ST CENTURY", DRUGS, ADIS INTERNATIONAL LTD, AT, (2003), vol. 63, no. 19, ISSN 0012-6667, pages 1973 - 1998, XP008039100 [A] 1-27 * page 1981 *

DOI:   http://dx.doi.org/10.2165/00003495-200363190-00002
 [A]  - EDWARDS P D ET AL, "DISCOVERY AND BIOLOGICAL ACTIVITY OF ORALLY ACTIVE PEPTIDYL TRIFLUOROMETHYL KETONE INHIBITORS OF HUMAN NEUTROPHIL ELASTASE", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (1997), vol. 40, no. 12, ISSN 0022-2623, pages 1876 - 1885, XP002927062 [A] 1-27 * table 2 *

DOI:   http://dx.doi.org/10.1021/jm960819g
by applicant   - PHYSIOL. LUNG CELL MOL. PHYSIOL., (2002), vol. 282, no. 2, pages L226 - 36
    - TAKAHASHI ET AL., TOXICOL APPL PHARMACOL., (1995), vol. 131, no. 1, pages 31 - 6
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.